BUDGET IMPACT ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR HEAMOPHILIA A PATIENTS WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Souza, P. [1 ]
Puopolo, G. R. [1 ]
Leme-Souza, R. [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Sao Paulo, SP, Brazil
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO36
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [41] BUDGET IMPACT ANALYSIS OF INCORPORATING ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Zuccaro, A. M.
    Fujii, F. A.
    Moretti, P.
    VALUE IN HEALTH, 2020, 23 : S144 - S144
  • [42] Etonogestrel-releasing subdermal contraceptive implant: Budget impact analysis based on the Brazilian private healthcare system
    da Silva Filho, Agnaldo Lopes
    Pereira Bueno, Ricardo Luis
    Ramires, Yohanna
    Cruz Lino, Lara Marina
    PLOS ONE, 2024, 19 (03):
  • [43] DIABETIC MACULAR EDEMA, BUDGET IMPACT ANALYSIS FROM THE PERSPECTIVE OF THE ALGERIAN PUBLIC HEALTH SYSTEM
    Chachoua, A.
    VALUE IN HEALTH, 2016, 19 (07) : A565 - A565
  • [44] BUDGET IMPACT ANALYSIS OF INSULIN DEGLUDEC COMPARED TO INSULIN GLARGINE U100 FOR TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Alves, J. S.
    Concalves, Td
    Griciunas, F.
    VALUE IN HEALTH, 2017, 20 (05) : A168 - A168
  • [45] COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Holanda, P.
    Salgado De Santana, C.
    Senna, T.
    Carmo, L.
    Alexandre, R. F.
    VALUE IN HEALTH, 2021, 24 : S96 - S96
  • [46] Budget Impact Analysis of HIV Testing in the VA Healthcare System
    Anaya, Henry D.
    Chan, Kee
    Karmarkar, Uday
    Asch, Steven M.
    Goetz, Matthew Bidwell
    VALUE IN HEALTH, 2012, 15 (08) : 1022 - 1028
  • [47] Photobiomodulation for Oral Mucositis - A Microcosting and Budget Impact Analysis from a Brazilian Perspective
    Bezerra, Paula Maria Maracaja
    de Lima, Thayana Maria Navarro Ribeiro
    Moura, Ana Beatriz Rodrigues
    Valenca, Ana Maria Gondim
    de Lucena, Edson Hilan Gomes
    Cavalcanti, Yuri Wanderley
    de Sousa, Simone Alves
    PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA, 2024, 24
  • [48] BUDGET IMPACT ANALYSIS OF TOCILIZUMAB UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
    Saggia, M. G.
    Santos, E. A.
    VALUE IN HEALTH, 2009, 12 (07) : A436 - A437
  • [49] Initial combination therapy for patients with pulmonary arterial hypertension (PAH): a budget impact analysis from the perspective of the Italian national healthcare system
    Barbieri, Marco
    Ghio, Stefano
    D'Alto, Michele
    Albera, Carlo
    Carignola, Renato
    Mule, Massimiliano
    Vitulo, Patrizio
    Vighini, Miriam
    Silvestri, Rosaria
    Zamboni, William
    Vizza, Carmine Dario
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (01): : 1 - 7
  • [50] BUDGET IMPACT ANALYSIS OF 5% LIDOCAINE MEDICATED PLASTER COMPARED WITH PREGABALIN OR GABAPENTIN MONOTHERAPY FOR THE TREATMENT OF DIABETIC POLYNEUROPATHY UNDER THE PERSPECTIVE OF BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Piedade, A. D.
    Kashiura, D.
    Engel, T.
    Rodrigues, C. R.
    VALUE IN HEALTH, 2017, 20 (05) : A214 - A214
12345